glp-1 ra medications New Guidelines for Type 2 Diabetes in 2025 List of approved and pending

In 2005, exenatide received FDA approval to treat diabetes under the name Byetta

Many clinical trials have proven GLP-1R agonists effectiveness and safety in treating or preventing obesity (14)

Effect of obesogenic medications on weight-loss outcomes in a behavioral weight-management program

Studies that include patients who are considered at-risk (i.e., diabetics, cardiac, elderly, etc.) and are currently taking GLP-1 RAs should also be performed as these patients may have compounding risk during the perioperative period which may make them more susceptible to complications related to GLP-1 use (Santos et al

On average weight loss, no

This study suggests that a small proportion of elective surgical patients, 6.2%, may present with a full stomach despite the recommended duration of fasting